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Interleukin(IL)-2 and inflammation regulate effector
andmemory cytolytic T-lymphocyte (CTL) generation
during infection.Wedemonstrateacomplex interplay
between IL-2 and inflammatory signals during CTL
differentiation. IL-2 stimulation induced the transcrip-
tion factor eomesodermin (Eomes), upregulated per-
forin (Prf1) transcription, and repressed re-expres-
sion of memory CTL markers Bcl6 and IL-7Ra.
Binding of Eomes and STAT5 to Prf1 cis-regulatory
regions correlated with transcriptional initiation
(increased recruitment of RNA polymerase II to the
Prf1 promoter). Inflammation (CpG, IL-12) enhanced
expression of IL-2Ra and the transcription factor
T-bet, but countered late Eomes and perforin induc-
tion while preventing IL-7Ra repression by IL-2.
After infection ofmicewith lymphocytic choriomenin-
gitis virus, IL-2Ra-deficient effector CD8+ T cells
expressedmore Bcl6 but less perforin and granzyme
B, formed fewer KLRG-1+ and T-bet-expressing CTL,
and killed poorly. Thus, inflammation influences both
effector and memory CTL differentiation, whereas
persistent IL-2 stimulation promotes effector at the
expense of memory CTL development.
INTRODUCTION
Naive CD8+ T cells differentiate into effector and memory cyto-
lytic T-lymphocytes (CTL) upon antigen stimulation in the context
of infection and inflammation. During this process, the differenti-
ating cells induce the expression of effector proteins such as the
cytokine IFNg, the pore-forming protein perforin, and a family of
serine esterases known collectively as granzymes (Cruz-Guilloty
et al., 2009; Harty et al., 2000). Perforin and granzymes areessential for cytolytic activity of CTL (Pipkin and Lieberman,
2007). IFNg, perforin, and granzymes are each induced at the
transcriptional level after activation, but distinct regulatory
mechanisms appear to be involved—most, if not all, antigen-
specific CD8+ T cells express IFNg and granzyme B during the
course of an infection, but only a fraction of these express per-
forin and IFNg expression does not necessarily correlate with
cytolytic activity (Harrington et al., 2008; Johnson et al., 2003;
Peixoto et al., 2007; Zaiss et al., 2008). The expression of all three
classes of effector genes in activated cells has been correlated
with memory CTL development (Bannard et al., 2009; Harrington
et al., 2008; Joshi et al., 2007; Opferman et al., 1999; Sarkar
et al., 2008). However, little is known about the signals that
regulate transcription of these different classes of effector genes
in activated CD8+ T cells, what mechanisms are involved, and
how those signals might regulate effector or memory CTL
differentiation.
The factors and mechanisms that drive the differential devel-
opment of effector versus memory CTL during clonal expansion
are not completely understood (Badovinac and Harty, 2007;
Kaech and Wherry, 2007; Williams and Bevan, 2007). A single
brief T cell receptor (TCR) stimulus (signal 1) combined with
costimulation (signal 2) can induce an extended period of prolif-
eration, acquisition of effector functions, and ultimately, memory
CTL formation (Kaech and Ahmed, 2001; Mercado et al., 2000;
van Stipdonk et al., 2001). The duration of TCR stimulation
mainly affects the magnitude of effector CD8+ T cell accumula-
tion (Prlic et al., 2006), whereas altered TCR signaling in the
context of mutant TCRs affects the balance of effector and
memory CTL development (Teixeiro et al., 2009).
IL-2 signals are sometimes considered part of signal 2 (Valen-
zuela et al., 2002). However, the role of IL-2 signaling in CD8+
T cell differentiation has been difficult to discern in vivo because
results from infection of IL-2-deficient mice have differed. This
variabilitymay reflect autoimmunity secondary to defective regu-
latory T cell development in IL-2-deficient mice (Bachmann and
Oxenius, 2007; Malek, 2008). More recent studies that avoided
these caveats have shown that IL-2 is essential for normalImmunity 32, 79–90, January 29, 2010 ª2010 Elsevier Inc. 79
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for programming the ability of memory CTL to reexpand upon
secondary infection in vivo (Bachmann et al., 2007; Williams
et al., 2006). In addition, IL-2Rb, an essential signaling subunit
of the IL-2R complex, and STAT5, a transcription factor acti-
vated by IL-2R stimulation, are required for normal expression
of perforin, granzyme B, and IFNg in activated CD8+ T cells
(Imada et al., 1998; Malek et al., 2001). Although both IL-2 and
IL-15 signal through IL-2Rb, each cytokine has different effects
on CTL differentiation; stimulation of IL-2Rb on CD8+ T cells in
cell culture with IL-2, as opposed to IL-15, favors effector rather
than memory CTL generation (Carrio et al., 2004; Manjunath
et al., 2001), suggesting that how IL-2Rb is activated affects
gene expression.
An inflammatory signal (signal 3) provided by cytokines such
as type I interferons and/or IL-12 is essential for normal effector
and memory CTL generation. In different settings, signal 3 has
been shown to be crucial for inducing CTL effector functions
(Curtsinger et al., 2003; Mescher et al., 2006), for driving
antigen-activated CD8+ T cells toward a short-lived effector
cell fate (Joshi et al., 2007), and for programming contraction
of the effector cell population (Badovinac et al., 2004). At the
same time, type I interferons and IL-12 have also been shown
to be required for memory CTL development (Xiao et al., 2009).
Thus, a number of extracellular signals regulate effector and
memory CTL development in vivo, but it is still unclear how these
signals act individually and in combination to regulate gene
expression programs in activated CD8+ T cells and control their
differentiation.
In this study, we used a simple cell-culture system to investi-
gate how the strength of IL-2R signaling regulated perforin
gene (Prf1) expression after TCR activation of naive CD8+
T cells and how inflammatory signals (CpG and IL-12) influenced
this process. We also investigated the requirement of IL-2
signaling for CTL responses in vivo in a setting that avoids
autoimmunity; mixed bone marrow chimeric mice reconstituted
with both wild-type and Il2ra-deficient cells were infected with
lymphocytic choriomeningitis virus (LCMV). We found that
persistent IL-2 stimulation induced Prf1 transcription and
promoted effector CTL differentiation, whereas inflammatory
signals had distinct effects. Our data indicate that inflammation
and IL-2 signals interface in a complex way and that their relative
strengths are likely to regulate the development of both effector
and memory CTL.
RESULTS
IL-2R Signal Strength Regulates Perforin Expression
and Cytolytic Function
To begin investigating how the ‘‘strength’’ of IL-2R signaling
regulated the effector functions of CD8+ T cells, naive CD8+
T cells were cultured for 2 days with a strong TCR stimulus in
conjunction with CD28 costimulation, then removed from stimu-
lation and recultured in low (10 U/ml) or high (100 U/ml) IL-2
concentrations. As an indirect measure of IL-2R signal intensity,
we assessed cell-surface expression of IL-2Ra, which is regu-
lated in part through a well-characterized positive feedback
loop in which STAT5 directly targets the Il2ra gene (Nakajima
et al., 1997). All cells displayed uniformly high expression of80 Immunity 32, 79–90, January 29, 2010 ª2010 Elsevier Inc.IL-2Ra until day 4, as judged by flow cytometry; after day 4, cells
cultured in high IL-2 maintained high IL-2Ra expression,
whereas cells cultured in lower IL-2 concentrations showed
decreased IL-2Ra expression (Figure S1A available online). Eval-
uating IL-2 signaling more quantitatively as the content of
tyrosine-phosphorylated STAT5 (Figures S1B and S1C), we
found that phospho-STAT5 amounts were high in cell popula-
tions cultured in either high or low IL-2 until day 5, after which
they were sustained in high IL-2 but declined abruptly in cells
cultured in low IL-2 (Figure S1B). At the single-cell level, flow
cytometric analysis showed that 94% of the cells cultured in
high IL-2, but only 15% of the cells cultured in low IL-2, main-
tained high amounts of phospho-STAT5 on day 6 (Figure S1C).
The mean fluorescence intensities (MFIs) of phospho-STAT5
staining in each population suggested that there was an
approximately 5- to 10-fold difference in IL-2 ‘‘strength’’ when
comparing 10 versus 100 U/ml IL-2 in our cultures.
The two essential effectors of the cytolytic program, perforin
and granzyme B, displayed distinct expression kinetics in acti-
vated CD8+ T cells under high or low IL-2 conditions (Figures
1A and 1B). Naive CD8+ T cells expressed perforin mRNA but
very little protein, and neither was induced by 2 days of TCR
stimulation. After removal from TCR stimulation, perforin
mRNA expression decreased until day 4, regardless of IL-2
concentration, then continued to decrease in cells cultured in
low IL-2, but increased strongly, beginning at day 5, in cells
cultured with high IL-2 (Figure 1A). Similarly, perforin protein
was strongly induced after day 4, when cells were cultured
in high IL-2 (Figure 1B). In contrast, granzyme B mRNA was
undetectable in naive T cells but was strongly induced by TCR
stimulation. Although granzyme B expression was maintained
in both low and high IL-2, granzyme B mRNA and protein were
both more highly expressed in cells cultured in high IL-2
(Figure 1A and 1B). The concentration of IL-2 in culture did not
affect the ability of CD8+ T cells to express IFNg and TNF upon
brief restimulation (Figure 1C), consistent with previous studies
(Bachmann et al., 2007; Williams et al., 2006), although IL-2Rb
was likely required initially (Malek et al., 2001).
Strong IL-2 signals were necessary to induce cytolytic func-
tion. ActivatedCD8+T cells cultureduntil day 6 in high IL-2 rapidly
killed antigen-pulsed target cells in a short-term (30 min–2 hr)
assay (Cruz-Guilloty et al., 2009), without prior restimulation
(Figure 1D and Figure S1D), whereas those cultured in low IL-2
did not (Figure 1D). Nevertheless, cells cultured in low IL-2 were
fully functional in all other respects—they accumulated exponen-
tially for at least 6 days, with kinetics equivalent to those of cells
cultured in high IL-2 (Figure 1E), and displayed efficient cytolytic
activity after a brief restimulation (Figure 1F). We attribute the de
novo increase in cytolytic activity to the strong induction of per-
forin in response to restimulation (Figure 1G).
Reciprocal Regulation of Perforin
and IL-7Ra Expression
The strength of IL-2 stimulation regulated the expression of addi-
tional genes in CD8+ T cells. As expected, initial stimulation of
naive P14 TCR transgenic CD8+ T cells, primed either by TCR
crosslinking or by coculture with splenic APCs loaded with
GP33 peptide, induced surface markers characteristic of
antigen-stimulated T cells (CD44hi, CD25hi, CD69hi, CD127).
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Figure 1. Different IL-2 Signal Strengths
Regulate Perforin and Granzyme B Expres-
sion to Establish CTL Function
(A) Kinetics of perforin and granzyme B mRNA
expression. Purified CD8+ T cells from naive B6
mice were primed with anti-CD3 and anti-CD28,
removed from the TCR stimulus after 2 days, and
recultured in 10 or 100 U/ml IL-2. Total RNA was
analyzed by blotting at the indicated times. Results
are representative of more than three independent
experiments. See also Figure S1.
(B) Perforin (left) and granzyme B (right) protein
expression. Whole-cell lysates were analyzed by
immunoblotting at the indicated times. Total
STAT5 content was used as a control. Granzyme
B expressionwas determined by intracellular stain-
ing and flow cytometry on day 6.
(C) Intracellular cytokine expression after restimu-
lation. CD8+ T cells were restimulated on days 4
and 6 with 10 nM PMA + 1 mM ionomycin for 6 hr.
(D) Flow cytometry-based cytotoxicity assay for
cytolytic activity. GP33-pulsed EL4 targets were
coincubated with effector P14 CD8+ T cells that
were differentiated as in (A). CTL activity was
blocked by incubation with 5 mM EGTA (data not
shown).
(E) Accumulation of CD8+ T cells after stimulation
as described in (A). The data are the mean and
standard deviation summarized from at least five
differentiations.
(F) Cytotoxic activity after brief restimulation. P14
cells cultured until day 5 in low IL-2 were restimu-
lated for 2 hr with PMA and Ionmycin, washed,
resuspended in T cell media without IL-2, and
cultured overnight before analyzing CTL activity.
(G) Perforin expression in primed CD8+ T cells
cultured in 10 U/ml IL-2 upon restimulation on
day 6. Lysates from cells left unstimulated (U) or
restimulated with PMA (P) and ionomycin (I) as in
(C) for 6 hr were analyzed by RNA blotting (left)
and immunoblotting (right).
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Effects of IL-2 and Inflammation on CTLAfter day 4, however, cells cultured in low IL-2 quickly converted
to a central memory-like phenotype (CD25lo, CD122hi, CD127 hi,
CD62Lhi) and were not cytolytic, whereas the majority of those
cultured in high IL-2 retained a characteristic effector phenotype
(CD25 hi, CD122hi, CD127, CD62Llo or ) and killed efficiently
(Figures S2A–S2C and data not shown).
We examined IL-7Ra (CD127) regulation in more detail
because effector cells that reinduce IL-7Ra at the peak of the
response to some acute infections are enriched for cells that
form long-lived memory CTL (Kaech et al., 2003). TCR stimula-
tion completely downregulated surface IL-7Ra expression, and
high IL-2 prevented IL-7Ra re-expression. However, IL-7Ra
was reinduced after day 4 in a dose-dependent fashion if the
IL-2 concentration was reduced (Figures 2A and 2B). IL-7Ra
re-expression did not correlate with cell division, because all
cells completely diluted CFSE (>7 divisions) by day 4 (Figure 2C)
and accumulated similarly until day 5, by which time IL-7Ra had
already been reinduced (Figure 2B; also see Figure 2D). At the
mRNA level, IL-7Ra mRNA was repressed and perforin mRNAwas reciprocally induced at the same high concentrations of
IL-2 (Figure 2D). Consistent with this observation, surface
expression of IL-2Ra and IL-7Ra chains was mutually exclusive:
even at low IL-2 concentrations (1–10 U/ml), IL-2Ra-positive
cells tended to be IL-7Ra negative (Figure 2D). Enforced expres-
sion of IL-2Ra by retroviral transduction confirmed that low IL-2
could repress IL-7Ra in cells that expressed higher IL-2Ra
(Figures S2D and S2E). Thus, expression of the high-affinity
IL-2Rabg receptor is sufficient to repress IL-7Ra re-expression,
even in cells cultured in low concentrations of IL-2.
Strong IL-2R Signals Sustain Blimp-1 Expression
and Repress Bcl-6
Distinctpopulationsof effectorCD8+Tcells arepresent early after
acute viral infection that have different potential to become
memory CTL, and they can be distinguished by their ability to
produce IL-2 and to proliferate upon secondary stimulation
exvivo (Joshi et al., 2007;Sarkaret al., 2008). These twoattributes
were controlled by different strengths of IL-2 stimulation inImmunity 32, 79–90, January 29, 2010 ª2010 Elsevier Inc. 81
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Figure 2. Reciprocal Regulation of Perforin
and IL-7Ra Reexpression by IL-2
(A) The regulation of IL-7Ra (CD127) re-expression
after priming. Purified naive P14 CD8+ T cells were
stained with antibodies against CD127 ex vivo
(Naive), after priming for 2 days with anti-CD3 +
anti-CD28 (day 2) and culture in 0.1, 1, 10 or
100 U/ml IL-2. The MFI of CD127 staining is shown
in each panel. The analysis is representative of at
least three separate differentiations. See also
Figure S2.
(B) Graphical summary of IL-7Ra expression from
the representative experiment in (A).
(C) Cell division history based on CFSE dilution
after priming and culture in IL-2 as in (A).
(D) IL-7Ra and perforin mRNA expression in naive
and primed P14 CD8+ T cells. Total RNA was
extracted at the indicated time points from cells
in (A).
(E) Flow cytometric analysis of IL-2Ra and IL-7Ra
coexpression.
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Effects of IL-2 and Inflammation on CTLculture. IL-2 production was not affected by different IL-2
concentrations through day 4 (Figure 3A), but by day 6, cells
cultured in low IL-2 producedmuchmore IL-2 upon restimulation
than cells cultured in high IL-2 (Figure 3A); they also proliferated
morestrongly in response to low levelsof stimulation (FigureS2F).
Studies of gene-disrupted mice have shown that Blimp-1 and
Bcl6 are required in vivo for the development of effector and
memory CTL, respectively (Ichii et al., 2002; Rutishauser et al.,
2009). We therefore examined whether IL-2 regulated expres-
sion of these two transcription factors. Blimp-1 mRNA was not
expressed in naive cells and was only induced upon removal
from the TCR stimulus and culture in IL-2 (Figure 3B). By day
6, Blimp-1 mRNA expression was not maintained in low IL-2,
but Blimp-1 remained expressed in high IL-2. Conversely, Bcl6
mRNA was expressed in naive CD8+ T cells, downregulated
during TCR stimulation, and re-expressed after day 4 in low,
but not high, IL-2, and this correlated inversely with expression
of IL-2Ra mRNA (Figure 3B). Thus, the inverse expression of
Blimp-1 and Bcl6 typical of effector cells in vivo was regulated
by the degree of IL-2 stimulation.
IL-2 Induces Perforin Gene Transcription through
STAT5 and Eomes, but not T-bet
The T-box transcription factors T-bet and Eomes are both
required for normal CTL differentiation (Intlekofer et al., 2008;82 Immunity 32, 79–90, January 29, 2010 ª2010 Elsevier Inc.Intlekofer et al., 2005; Joshi et al., 2007).
We asked whether IL-2 stimulation regu-
lated expression of T-bet and Eomes
upon CD8+ T cell activation. Expression
of T-bet and Eomes mRNA and protein
was low or undetectable in naive CD8+
T cells. Two days of TCR stimulation
strongly induced T-bet (Figure 3C), and
its expression was maintained in an
IL-2-independent manner through day 6
(Figure 3C). In contrast, Eomes was
induced by day 4 and was upregulated
through day 6 in a manner stronglydependent on IL-2 concentration in culture (Figure 3C). By
switching cells from low to high IL-2 and vice versa on day 4 of
culture, we confirmed that Eomes and perforin expression
were both regulated by IL-2, whereas T-bet expression was
not (Figure 3D and data not shown).
The kinetics and IL-2 dependence of Eomes expression was
closely paralleled by perforin expression (Figures 3C and 2D),
leading us to ask whether Eomes could induce perforin without
strong IL-2 stimulation. Under these conditions, endogenous
Eomes was not highly expressed and STAT5 phosphorylation
was low (Figures 3C and 3D and Figures S1B and S1C). We
activated purified naive CD8+ T cells from wild-type and T-bet-
deficient B6 mice for 2 days, transduced them with a retrovirus
expressing a hyperactive form of Eomes (Eomes-VP16) linked
to IRES-GFP, then cultured the cells in low IL-2. Cells infected
with Eomes-VP16, but not the control GFP retrovirus, strongly
expressed perforin mRNA on day 6 (Figure 3E). Eomes-VP16
had no effect on the expression of granzyme B mRNA (Fig-
ure 3C). Control experiments showed that the effect of Eomes
could not be attributed to a large increase in IL-2Ra or IL-2Rb
expression (Figure S3). Thus, Eomes most likely acts directly at
Prf1 after induction by IL-2.
We tested this hypothesis by chromatin immunoprecipitation
(ChIP) (Figure 4). Endogenous Eomes and STAT5 proteins both
bound toPrf1 on day 6 in cells cultured in high IL-2, although their
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Figure 3. IL-2 Regulates Blimp-1, Bcl6, and
Eomes Expression, and Eomes Activates
the Perforin Gene
(A) Intracellular staining of IL-2. Stainings are of
unstimulated cells (outlined histogram) or cells
restimulated for 4 hr with 10 nM PMA + 1 mM
ionomycin (shaded histograms). Results from
(A)–(E) are representative of at least two indepen-
dent experiments.
(B) Blimp-1, Bcl6, and IL-2Ra mRNA expression
kinetics were analyzed by RNA blotting.
(C) T-bet and Eomes mRNA expression kinetics
were analyzed by RNA blotting.
(D) Eomes and perforin expression in response
to IL-2 after day 4. Cultured CD8+ T cells were
harvested and washed on day 4 and switched
from low IL-2 to high IL-2 and vice versa (switch)
or returned to their original IL-2 media (control)
for an additional 2 days. Whole-cell lysates were
generated and analyzed by immunoblotting on
day 6.
(E) Perforin and granzyme B (GrzmB) mRNA
expression upon Eomes-VP16 transduction. On
day 6 of culture in 10 U/ml IL-2, total RNA was
analyzed by RNA blotting; uninfected (uninf),
Eomes-VP16 (Eo-VP), or empty cassette (GFP)
transduced; Th1 and NIH 3T3 cells are shown as
controls. Transduction efficiency in each culture
was equivalent between constructs. See also
Figure S3.
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Effects of IL-2 and Inflammation on CTLbinding patterns were distinct. STAT5 primarily bound DNase I
hypersensitive (DHS) site 4 at –1 kb and within intron 3 down-
stream of DHS7, comparable to its binding to the TSS of Il2ra,
a known STAT5 target gene (Nakajima et al., 1997) (Figure 4B).
Eomes bound to the Prf1 transcription start site (TSS) and to
a lesser degree DHS4 (Cruz-Guilloty et al., 2009), comparable
to its binding to the TSSs of Il2rb and Ifng, genes that are direct
targets of Eomes (Intlekofer et al., 2005). Eomes also bound
modestly near DHS7 (Figure 4B). Compared to cells cultured in
high IL-2, cells cultured in low IL-2 showed considerably less
binding of STAT5 and Eomes to Prf1, consistent with their lower
phospho-STAT5 content and lower Eomes expression (Fig-
ures 4A and 4B). However, the amount of binding was still
somewhat greater than that observed at the TSS of ll4 and
Hprt, genes that are not expressed in CD8+ T cells or that are
expressed, but not regulated, by IL-2, respectively. Therefore,
even low binding of phospho-STAT5 and Eomes to the Prf1
gene may be relevant.
Prf1 Transcription Is Regulated by Recruitment
of RNA Polymerase II
TCR stimulation of naive CD4 T cells leads them to differentiate
into distinct subsets with respect to expression of cytokine
genes, a process that involves differential chromatin remodeling
of specific cytokine gene loci (Ansel et al., 2006; Avni et al., 2002;Immunity 32, 79–90Fields et al., 2002; Grogan et al., 2001).
Because activated CD8+ T cells differen-
tiated in high IL-2 express at least 20
times more perforin mRNA and exhibit
a differentially remodeled DNase I hyper-sensitivity (DHS) site pattern in the Prf1 locus compared to differ-
entiated Th1 cells (Pipkin et al., 2007), we asked whether differ-
ential perforin expression by CD8+ T cells in response to low
versus high IL-2 was accompanied by differences in the DHS
site pattern surrounding Prf1 (Figure S4) (Pipkin and Lichtenheld,
2006). Unexpectedly, we found that there was no difference in
the pattern of DHS sites across200 kb of the Prf1 locus regard-
less of whether the cells had been differentiated in low or high
IL-2 (Figure S4 and data not shown). Thus, IL-2 signals did not
appear to ‘‘open’’ IL-2 specific cis-regulatory regions in the
Prf1 gene but, rather, acted on a previously opened locus.
We asked whether IL-2 stimulation regulated recruitment of
RNA polymerase II (Pol II) (Figure 4C). Relative to cells differenti-
ated in low IL-2, cells differentiated in high IL-2 exhibited dramat-
ically increased recruitment of Pol II to the Prf1 TSS at day 6,
along with a small increase in Pol II density across the gene
body (Figure 4C). Conversely, Pol II was recruited efficiently to
the Il7ra TSS in CD8+ T cells cultured in low IL-2, but not in cells
cultured in high IL-2 (Figure 4D). In both high and low IL-2, the
level of Pol II binding at the Prf1 TSS was greater than that
observed at the TSS of the muscle-specific geneMyoD1, which
is not expressed in T cells (Figure 4C). Pol II binding at the TSS of
the housekeeping gene Hprt (not regulated by IL-2) was compa-
rable to the level of Pol II binding at the Prf1 TSS in high IL-2 (data
not shown). Thus, the strength of IL-2 stimulation determined, January 29, 2010 ª2010 Elsevier Inc. 83
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Figure 4. IL-2 Regulates RNA Polymerase II
Recruitment and the Binding of STAT5 and
Eomes to Prf1
(A) ChIP analysis of endogenous STAT5. Chro-
matin was isolated from cells on day 6. The
efficiency of recovery relative to input at the 1 kb
region of Prf1 was 0.39% in high-IL-2 conditions
for STAT5. The data in panels (A) and (B) show
the mean and standard deviation of duplicate
measurements, pooled from at least two immuno-
precipitations of chromatin prepared from two
independent CD8+ T cell differentiations. See
also Figure S4.
(B) ChIP analysis of endogenous Eomes. The
efficiency of recovery relative to input for the1 kb
region of Prf1 was 0.97% in high-IL-2 conditions
for Eomes.
(C) ChIP analysis of RNA pol II. Data show the
mean and standard deviation of duplicate mea-
surements from separate immunoprecipitations
from at least two independent differentiations;
data from each differentiation was normalized
based upon binding of RNA pol II to the Hprt
TSS. The efficiency of recovery of the Hprt TSS
was 0.6% and was approximately six times
greater than from the Ifng TSS.
(D) ChIP analysis of RNA pol II at the Il7ra TSS from
the chromatin analyzed in (C).
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Effects of IL-2 and Inflammation on CTLwhether Pol II was recruited to the Prf1 and Il7ra genes in acti-
vated CD8+ T cells.
IL-2RaDeficiency Impairs the Differentiation of Effector
CD8+ T Cells into CTL In Vivo
To examine the effect of IL-2 upon effector CD8+ T cell differen-
tiation, we generated mixed bone marrow chimeras by transfer-
ring a mixture of congenically distinct wild-type and IL-2Ra-defi-
cient bone marrow cells into lethally irradiated B6 mice and
infecting them with LCMV (Bachmann et al., 2007; Williams
et al., 2006). Eight days after infection, CD44hi, antigen-experi-
enced Il2ra+/+, and Il2ra/ CD8+ T cells were sorted and
their cytotoxic activity was analyzed in a standard chromium
release assay using GP33 peptide-loaded targets. Despite equal
representation of GP33-specific cells among wild-type and
Il2ra/ effectors based on tetramer staining (data not shown),
Il2ra/ CD8+ T cells were severely defective in their capacity84 Immunity 32, 79–90, January 29, 2010 ª2010 Elsevier Inc.to lyse targets: 10-fold more effectors
were needed for comparable target cell
lysis (Figure 5A). This impairment corre-
lated with decreased expression of per-
forin and granzyme B mRNA in sorted
Il2ra/ CD44hi cells compared to wild-
type cells (Figure 5B). In addition, on
day 6 after infection, when responding
wild-type CD8+ T cells expressed maxi-
mal IL-2Ra, fewer total Il2ra/ CD8+
T cells expressed granzyme B, T-bet, or
KLRG-1, compared to wild-type cells,
whereas proportionally more knockout
cells expressed IL-7Ra and CD62L (Fig-ure 5C and data not shown) (Williams et al., 2006). Furthermore,
Il2ra/ CD8+ T cells contained a much larger proportion of
effector cells that coproduced IFNg and IL-2 upon restimulation
and expressed much more Bcl6 mRNA (Figures 5D and 5E).
Thus, CD8+ T cells that could not signal via high affinity IL-2Rs
differentiated inefficiently into effector CTL, even in an environ-
ment containing normal cells and inflammatory signals.
IL-2 Signaling Reduces Memory CTL Formation,
but not Secondary Re-expansion
To determine the in vivo fate of in vitro-activated CD8+ T cells, we
transferred primed P14 TCR-transgenic CD8+ T cells that had
been cultured in high or low IL-2 to naive B6 mice (mixed at a
1:1 ratio, Figure 6). Engraftment of cells cultured in high and
low IL-2 18 hr after transfer was equivalent in both the spleen
(Figure 6A) and the lung (data not shown), and this equal repre-
sentation wasmaintained when the mice were bled 10 days later
Granzyme B
WT Il2ra-/-
0
5
10
15
20
R
el
at
iv
e
Ex
pr
es
sio
n
Perforin
0
1
2
3
4
5
B
C
A
51
CD25T-bet Granzyme B KLRG1
Day 6 post LCMV infection gated CD8+ CD44hi
Il2ra+/+
Il2ra-/-
77
56
44
31
45
27
WT Il2ra-/-
PMA+Iono
8.9
8.6
10
8.1
7.8
54
26
21
Uninfected Day 6 p.i.
(13)
(55)
Bcl6
0.00
0.01
0.02
0.03
0.04
0.05
Day 6 Day 8
0.06
Il2ra+/+
Il2ra-/-
R
el
at
iv
e
e
xp
re
ss
io
n
D
IFN
IL
-2
+/+
-/-
Il2ra
E
1 10 100
0
6
12
18
24
E:T Ratio
%
Sp
ec
ific
Ly
si
s
Il2ra+/+
Il2ra-/-
0.05
0.8
0.4
0.2
0.7
1.2
0.5
4.9
1.6
4.6
No peptide 0.1µM GP33
Day 6 p.i.- LCMV
(35)
(10)
Figure 5. IL-2Ra-Deficient CD8+ T Cells Are
Impaired in CTL Differentiation upon LCMV
Infection
(A) Il2ra+/+ and Il2ra/ mixed bone marrow
chimeric (BMC) mice were infected with LCMV.
Eight days postinfection, Il2ra+/+ and Il2ra /
CD44hi CD8+ effector cells were sorted and their
ability to kill GP33 peptide-pulsed target cells
was assayed.
(B) Quantitative RT-PCR analysis of cDNA
prepared from sorted CD44hi Il2ra+l+ and Il2ra/
CD8+ T cells. Values were normalized based on
amplification of Hprt mRNA.
(C) Percent of total Il2ra+/+ (upper number) and
Il2ra/ (lower, gray number) CD8+ T cells from
mixed BMC mice that express the indicated
proteins was determined 6 days post-LCMV infec-
tion. CD25 expression by the Il2ra+/+ cells is de-
picted. Dashed line shows staining in uninfected
BMC mice.
(D) Intracellular cytokine production of IL-2 and
IFNg by Il2ra+/+ and Il2ra/ effector CD8+
T cells. Splenocytes from uninfected BMC mice
and BMC mice on day 6 postinfection were stimu-
lated for 4 hr with GP33 peptide, or PMA (50 ng/ml)
and Ionomycin (500 ng/ml). Red numbers indicate
the percentage of IL-2+ events among IFNg+ cells.
(E) Quantitative RT-PCR analysis of cDNA
prepared from sorted CD44hi Il2ra+l+ and Il2ra/
CD8+ T cells. Values were normalized based on
amplification of Hprt mRNA.
Panels (A)–(E) are representative results from at
least three independent experiments with at least
two mice per time point.
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after transfer (41 days after initial TCR activation in vitro), the
P14 cells that had been cultured in low IL-2 maintained their
frequencies, whereas those that had been cultured in high IL-2
had decreased in frequency and absolute number in all tissues
analyzed (Figures 6A and 6B). Although cells from the high IL-2
cultures maintained some CD62Llo cells both 10 and 35 days
after transfer, cells from the low IL-2 cultures were essentially
all CD62Lhi (Figure 6C). Thus, the differential phenotypic
programming observed in vitro was preserved upon in vivo
transfer, indicating that T cells that had received higher and
more prolonged IL-2 signals were impaired for memory differen-
tiation.
As a functional read-out for the fitness of thememory P14 cells
derived fromculture in varying concentrations of IL-2,we infected
recipient mice with LCMV 35 days after transfer. Five days after
infection, both populations of P14 T cells robustly expanded in
the spleen, lymph nodes ,and liver; despite the fact that the P14
cells differentiated in low IL-2 were represented at an increased
frequency prior to rechallenge, they did not exhibit an advantage
upon re-expansion (Figures 6D and 6E). Thus, with CD8+ T cells
from this in vitro system, alterations in IL-2 exposure altered
their differentiation tomemory but did not subsequently influence
their ability to respond to secondary stimulation.Inflammatory Stimuli and IL-2R Signals Have
Cooperative and Opposing Effects
Given that both IL-2 and inflammation regulate CTL develop-
ment, we examined how inflammatory stimuli interfaced with
IL-2 signals to control gene expression in activated CD8+
T cells. We primed naive P14 CD8+ T cells with APCs and
GP33 peptide, with or without inflammation (CpG), followed by
culture in high or low IL-2 with or without IL-12 (Figure 7). The
kinetics of perforin and granzyme B mRNA expression in cells
primed with peptide and APC were similar to those previously
observed after priming with plate-bound aCD3 and aCD28 (Fig-
ure 7A, compare with Figure 1A). However, compared to cells
stimulated with GP33 peptide alone, cells stimulated in the
presence of CpG followed by culture in IL-12 and low IL-2
upregulated T-bet and IL-2Ra mRNA, as well as CD25 surface
expression (Figures 7A and 7B). IL-2Ra upregulation occurred
prior to the initial cell division (Figure 7C) in a manner that was
largely resistant to treatment with blocking antibodies to IL-2
(Figure 7D; Figure S5), suggesting that IL-2Ra expression was
induced prior to, and independently of, feedback through IL-2/
STAT5. In addition, inflammation increased the peak amount of
IL-2Ra mRNA and surface protein expression in cells cultured
in low IL-2 and sustained CD25 expression beyond the precipi-
tous drop otherwise seen at day 3 in the absence of inflammationImmunity 32, 79–90, January 29, 2010 ª2010 Elsevier Inc. 85
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Figure 6. Strong IL-2 Signals Negatively
Impact CD8+ T Cell Memory Formation
without Impairing Secondary Expansion
(A) 2.5 3 105 congenically marked P14 cells that
had been differentiated in high (100 U/ml) or low
(10 U/ml) concentrations of IL-2 were transferred
in a 1:1 mix to the same recipient. Representative
mice were analyzed for the presence of the trans-
ferred cells in the spleen or lung (data not shown)
18 hr and 35 days after transfer.
(B) Thirty-five days after transfer, the presence of
the transferred P14 cells was determined (pLNs,
peripheral lymph nodes). FACS plots are gated
on total CD8+ T cells. High (H) IL-2 (Thy1.2+);
Low (L) IL-2 (Thy1.2).
(C) CD62L expression on transferred P14 cells in
the blood.
(D) Thirty-five days after P14 transfer, recipient
mice were infected with LCMV. Five days later,
the frequency of the transferred P14s of total
CD8+ T cells was determined in the liver and
mesenteric lymph nodes (mLNs).
(E) Absolute number of P14 T cells was determined
in the spleens of representative mice before (day
35 after transfer) and after (day 5) LCMV infection.
Data depicts average numbers ± SEM of at least
two mice per time point per group.
Panels (A)–(E) are representative results from two
independent experiments.
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Effects of IL-2 and Inflammation on CTL(Figures 7A and 7B). Although inflammation itself enhanced
IL-2Ra expression, high IL-2 still upregulated IL-2Ra expression
further in cells primed with inflammation (Figure 7A). Together,
these data showed that by increasing the early expression of
IL-2Ra, inflammation enhanced the duration and responsive-
ness of activated CD8+ T cells to IL-2 signals.
Nevertheless, some of the effects of high IL-2, namely upregu-
lation of perforin and Eomes, were different when inflammatory
signals were present (Figure 7A). Inflammatory signals during
priming impaired the ability of high IL-2 to induce Eomes and
perforin at later times (Figure 7A; Figure S5). In addition, they
impaired the ability of high IL-2 to repress IL-7RamRNA expres-
sion. Thus, inflammatory stimuli prolonged IL-2 responsiveness
but, paradoxically, also interfered with the ability of IL-2 to
regulate certain genes.
DISCUSSION
Here, we tested the hypothesis that different ‘‘strengths’’ of IL-2
stimulation induce different transcriptional responses that alter
CD8+ T cell differentiation. We showed that increasing IL-2R86 Immunity 32, 79–90, January 29, 2010 ª2010 Elsevier Inc.signal strength promoted effector CTL
differentiation in a simple cell-culture
system and that IL-2R signals were
required for normal gene expression and
accumulation of effector CTL during viral
infection. Moreover, we showed that
inflammatory stimuli (CpG/IL-12) potenti-
ated early IL-2 responsiveness but simul-
taneously altered the transcriptional
programs induced by IL-2. Our findingsare consistent with those of an accompanying study (Kalia
et al., 2010) reporting that viral infection induces some effector
cells to express more IL-2Ra for a longer duration than others
and that these cells are both more responsive to IL-2 and more
prone to differentiate into effector rather than memory CTL.
CD8+ T cell differentiation upon infection is complex and inte-
grates multiple signals including strength of TCR stimulus and
costimulation, IL-2R signals, and inflammation (Williams and
Bevan, 2007). We found that IL-2 regulated perforin and gran-
zyme B expression independently of inflammation (CpG and
IL-12), a result that seems to contradict previous studies
showing that inflammatory signals were obligatory for inducing
cytolytic function (Curtsinger et al., 2003). The difference could
lie in the strength of initial TCR signals: Curstsinger et al. primed
naive cells with MHC I-peptide and B7-coated microspheres to
mimic APC, and under these conditions, initial IL-2Ra induction
was low and transient and strongly dependent on inflammation
for sustained expression in the presence of low IL-2 concentra-
tions (Curtsinger et al., 2003; Valenzuela et al., 2002). In contrast,
we used plate-bound anti-CD3 and anti-CD28 or live APC
with high concentrations of peptide, conditions that maintained
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Figure 7. Inflammatory Signals and IL-2 Signal Strength Induce Distinct Transcriptional Regimes
(A) The kinetics of mRNA expression in the presence and absence of inflammation. Naive P14 CD8+ T cells were stimulated by coculture with GP33 peptide (blue)
and APCs, with or without CpG (red), for 2 days (d2) and then were recultured, with or without IL-12 (CpG/IL-12), in low (10 U/ml) or high (100 U/ml) IL-2. See also
Figure S5.
(B) The kinetics of surface IL-2Ra expression. P14 CD8+ T cells were primed with GP33 and APCs and cultured under the indicated conditions. IL-2Ra expression
was determined by flow cytometry.
(C) IL-2Ra expression prior to the first cell division. Naive P14 cells were loaded with CFSE and primed as shown in (B). After 36 hr, cells that had not diluted CFSE
were gated, and IL-2Ra expression was determined by flow cytometry and is shown relative to naive cells stained prior to stimulation.
(D) IL-2Ra expression in the presence of blocking aIL-2 antibody during priming. Cells were cultured as in (B).
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Effects of IL-2 and Inflammation on CTLIL-2Ra expression without a requirement for inflammatory
signals. Our studies revealed that IL-2 enhanced perforin tran-
scription, whereas CpG and IL-12 did not. We hypothesize that
in conditions of weak TCR stimulation, inflammation enables the
IL-2 responsiveness that is necessary for expression of perforin
and granzyme B; however, inflammation is less critical under
conditions of strong TCR stimulation.
Increased inflammation promotes ‘‘short-lived’’ effector CTL
development, programs clonal contraction, and induces CTL
effector functions (Badovinac et al., 2004; Curtsinger et al.,
2003; Joshi et al., 2007). Somewhat counterintuitively, inflamma-tory signals also appear to be required for memory CTL develop-
ment (Xiao et al., 2009). In the simplified cell-culture setting, our
results showed that inflammation could regulate both effector
and memory CTL development in the context of different
strengths of IL-2 signals. On the one hand, inflammatory signals
increased T-bet and IL-2Ra expression even in low IL-2 condi-
tions, whereas without inflammation, strong IL-2R signals
increased Eomes, perforin, and granzyme B expression. Thus,
both inflammation and IL-2 promoted aspects of effector CTL
differentiation. On the other hand, however, as best seen in our
high IL-2 conditions, inflammatory signals attenuated the lateImmunity 32, 79–90, January 29, 2010 ª2010 Elsevier Inc. 87
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Effects of IL-2 and Inflammation on CTLexpression of perforin and Eomes and increased IL-7Ra expres-
sion, counteracting certain effects of persistent IL-2 signals.
Thus, the generation of effector and memory CTL during infec-
tion in vivo is likely to be determined by the relative balance of
TCR, costimulatory, inflammatory, IL-2, and IL-15 signals
encountered by individual responding cells and possibly addi-
tional unidentified signals as well.
Analysis of CD8+ T cell differentiation after activation in vitro
and the CD8+ T cell response to LCMV in the absence of IL-2R
signals in vivo supports two conclusions regarding the roles of
IL-2. First, IL-2Ra-deficient CD8+ T cells in vivo resembled cells
cultured in low concentrations of IL-2: both types of cells showed
reduced perforin and granzyme B expression, as well as prema-
ture re-expression of IL-7Ra, CD62L, and Bcl6. Thus, strength
of IL-2 stimulation directly regulated expression of genes char-
acteristic of both effector and memory CTL. Second, IL-2Ra-
deficient CD8+ T cells developed proportionally fewer KLRG-1-
and T-bet-expressing effector cells relative to wild-type CD8+
T cells near the peak of the LCMV response. This was unlikely to
be due to a direct effect of IL-2 upon T-bet expression because
IL-2 did not regulate T-bet in CD8+ T cells primed in culture.
Therefore, IL-2 appeared to drive selectively the accumulation
of primed effector CD8+ T cells that had already induced T-bet.
These two conclusions are consistent with those of an accompa-
nying study, demonstrating that CD25hi effector CD8+ T cells
(i.e., more IL-2-responsive) generated during LCMV infection
exhibited a more effector-like gene expression profile, prolifer-
ated more extensively at the tail-end of the effector phase, and
contributed inefficiently to the formation of memory CTL relative
to CD25lo effector cells (Kalia et al., 2010).
Our results help to clarify the regulation of T-bet and Eomes
during CD8+ T cell activation. As expected, T-bet was induced
upon TCR stimulation; however, we found that Eomes was
induced in response to IL-2 several days after removal from
the TCR stimulus. The induction of T-bet by TCR signals, and
Eomes by IL-2 stimulation, might partially explain the sequential
upregulation of T-bet and Eomes during infection (Intlekofer
et al., 2005). In addition, we found that the presence of CpG at
priming was sufficient to repress later Eomes induction by IL-2
(data not shown). Previous studies have shown that T-bet and
Eomes are inversely regulated in activated CD8+ T cells by
IL-12 (Takemoto et al., 2006). However, CpG stimuli did not
enhance T-bet expression, unless exogenous IL-12 was also
provided (Joshi et al., 2007; Szabo et al., 2002). Thus, T-bet-
independent pathways are likely to prevent Eomes upregulation
by effector cells.
Both T-bet and Eomes can positively regulate IL-2Rb expres-
sion in CTL (Intlekofer et al., 2008; Intlekofer et al., 2005; Joshi
et al., 2007). Here, we showed that IL-2 induced Eomes. In
conjunction with the previous studies, our results are consistent
with the hypothesis that T-bet and Eomes operate in feedback
loops. For example, T-bet could initiate elevated IL-2Rb expres-
sion to enable later IL-2-induced Eomes upregulation that feeds
back to increase Il2rb even further; Eomes together with phos-
pho-STAT5 would then feed forward to activate late effector
genes such as Prf1. Our data suggest that inflammation could
be important to initiate this process by enhancing T-bet and
IL-2Ra expression. However, we also showed that strong inflam-
mation inhibited Eomes upregulation by IL-2 and, thus, could88 Immunity 32, 79–90, January 29, 2010 ª2010 Elsevier Inc.result in effector cells that fail to upregulate Eomes and IL-2Rb
expression efficiently. Thus, the paradoxical positive and nega-
tive effects of inflammation on the development of both effector
andmemory CTL in vivo could relate in part to positive and nega-
tive effects of inflammation on IL-2-regulated gene expression.
Finally, our data confirm previous studies implicating IL-2 as
an important regulator of Prf1 transcription (Zhang et al., 1999)
and provide additional mechanistic insights as to how IL-2 medi-
ates Prf1 gene activation. Under the conditions we examined,
IL-2 did not induce global chromatin remodeling of previously
reported DHS sites (Pipkin et al., 2007) but acted on a previously
‘‘opened’’ locus. Our data suggest that the main mechanism of
gene activation by IL-2 is increased transcription initiation via
increased RNA Pol II recruitment to the TSS, as opposed to stim-
ulated elongation of preinitiated Pol II complexes. In addition,
RNA Pol II loading at the promoter was coordinated with binding
of endogenous STAT5 at an enhancer located at 1 kb, previ-
ously shown to be controlled by STAT5 in transient reporter
assays (Zhang et al., 1999). Moreover, Eomes bound to the
1 kb enhancer and the TSS concurrently with STAT5 and RNA
Pol II, suggesting that STAT5 and Eomes might participate in re-
cruiting RNA Pol II. At the same time, RNA Pol II was recruited
away from the Il7ra transcription start site under persistent IL-2
signaling, suggesting that IL-2-mediated regulation of RNA Pol
II recruitment to and away from accessible genes might be a
general mechanism for controlling the differentiation of activated
CD8+ T cells.EXPERIMENTAL PROCEDURES
Mice, Chimeras, and Infections
CD8+ T cells were isolated from 4- to 12-week-old Tcra /3 P14 TCR trans-
genic (Taconic), C57BL6/J or Tbx21/mice (Jackson Laboratory). P14 CD8+
T cells were uniformly naive based on staining with antibodies recognizing
CD25, CD44, CD62L, and CD122. All mice were maintained in specific path-
ogen-free barrier facilities and used according to protocols approved by
the Immune Disease Institute and Harvard Medical School animal care and
use committees. For bone marrow chimeric mice and LCMV infection, 6- to
8-week-old B6.SJL-PtprcaPep3b/BoyJ (CD45.1) mice were purchased from
the Jackson Laboratory. B6.SJL 3 B6 (CD45.1/CD45.2, heterozygote) and
B6.129S4-Il2ratm1Dw/J (Il2ra/, CD45.2) mice were bred in our facility at the
University of Washington (Seattle, WA) under specific pathogen-free condi-
tions. Bone marrow preparations from the femur and tibia of donor mice
were incubated with anti-CD3-, CD4- and CD8-biotin, followed by anti-biotin
magnetic beads, and applied to LS columns for depletion of T cells (Miltenyi).
2–5 3 106 total T cell-depleted bone marrow cells, containing a roughly 1:1
mixture of wild-type and IL-2Ra-deficient bone marrow, were injected intrave-
nously into lethally irradiated B6.SJL hosts (1000 Rad). Mice were infectedwith
2 3 105 PFU of LCMV-Armstrong intraperitoneally 10–12 weeks posttrans-
plant.
Isolation, Culture, and Retroviral Transduction of Primary
CD8+ T Cells
CD8+ T cells were purified (>95%purity) by negative selection (Invitrogen) from
RBC-lysed single-cell suspensions from pooled spleen and lymph node cells.
For stimulation, purified CD8+ T cells were cultured in Dulbecco’s modified
Eagle’s medium (DMEM) supplemented with 10% heat-inactivated fetal calf
serum, 2 mM L-glutamine, penicillin-streptomycin, nonessential amino acids,
sodium pyruvate, vitamins, 10 mM HEPES, and 50 mM 2-mercaptoethanol
as 4 3 105 cells/cm2 in T25 flasks coated with anti-CD3 (clone 2C11) and
anti-CD28 (clone 37.51) (1 mg/ml) by precoating with 300 mg/ml goat anti-
hamster IgG. After 48 hr, cells were removed from the TCR signal and recul-
tured at a concentration of 5 3 105 cells/ml in media supplemented with the
Immunity
Effects of IL-2 and Inflammation on CTLindicated concentration of recombinant human IL-2 (rhIL-2). For activation of
P14 CD8+ T cells with APCs, combined spleen and lymph nodes were used
to generate single-cell suspensions after RBC lysis. Washed cells resus-
pended in complete in T cell media as 4 3 106 cells/ml and GP33 peptide
was added to 1 mM final concentration and were untreated or supplemented
with 3 ng/ml CpG (ODN1826, Invivogen, Inc.). After 48 hr, CD8+ T cells were
purified by negative selection for direct analysis, or cocultures were counted
and recultured as 5 3 105 cells/ml in rhIL-2-containing media either with or
without a single dose of IL-12 to 5 ng/ml. Purified naive P14 CD8+ T cells
were also activated with mitomycin C-treated APCs from B6 Tcra/ spleens
and gave similar results (data not shown). Every 24 hr, cells were counted and
readjusted to 5 3 105 cells/ml with fresh media containing 10 or 100 U/ml
rhIL-2. Viral supernatants were generated by transfection of Phoenix pack-
aging cells and concentration by overnight centrifugation at 6000 3 g. At
42 hr after TCR priming of 106 CD8+ T cells in 1 ml per well in 12-well plates,
the culture media was replaced with complete media supplemented with 8 mg/
ml polybrene containing concentrated virus. The plates were centrifuged at
700 3 g for 1 hr at room temperature and then incubated at 37C for 5 hr.
Retroviral constructs for Eomes-VP16 and the MIG control empty vector
were a gift from Dr. Steve L. Reiner (Intlekofer et al., 2005).
Cytotoxicity Assays
For flow cytometric killing analysis, EL-4 thymoma target cells were loaded
with 0 or 1 mM GP33 peptide for 2 hr before a 2 hr coincubation with P14
CD8+ T cells in 96-well round-bottom plates (Cruz-Guilloty et al., 2009). After
coincubation, cells were stained with AnnexinV-FITC and anti-CD8+-APC.
For standard killing assays, bulk, polyclonal CD44hi wild-type, and Il2ra/
CD8+ effector T cells from spleens of mixed BMC mice, infected 8 days prior
with LCMV, were FACS-sorted based on congenic marker expression. EL-4
cells were labeled with 51Cr (Perkin Elmer) for 1 hr at 37C,washed extensively,
and then incubated with effector cells (adjusted for proportion of antigen-
specific cells based on staining an aliquot of each population with Db-GP33
tetramer) with either 10 mM GP33 peptide or no peptide for 4 to 5 hr at 37C.
Percent specific lysis from duplicate or triplicate wells was determined relative
to the spontaneous (targets alone) and total release (2% Triton X-100 deter-
gent) controls, as described previously (Tyznik et al., 2004).
Chromatin Immunoprecipitation and Real-Time PCR Analysis
Chromatin immunoprecipitation (ChIP) was performed as described (Cruz-
Guilloty et al., 2009). Briefly, formaldehyde-fixed chromatin was isolated
from 2–43 107 CD8+ T cells for each immunoprecipitation and was sonciated
to yield 0.5–1 kb chromatin fragments. Immunoprecipitation was performed by
adding optimized antibody amounts (see Supplemental Experimental Proce-
dures), followed by overnight incubation at 4C; protein A-sepharose beads
were added for the last 3 hr of the incubation. After bead washes, chromatin
was treated with RNase A for 1 hr at 37C, followed by addition of Proteinase
K and overnight incubation at 65C to reverse crosslinking, and DNA was
purified with QIAquick columns (QIAGEN). For real-time PCR detection of
immunoprecipitated targets using the SYBR Green PCR kit, a standard curve
was generated for each sample based on amplification of serial dilutions of
input DNA. ChIP DNA PCR reactions were performed in duplicates. Agarose
gel analysis and melt curves were analyzed to ensure amplification of specific
target sequences.
Additional Experimental Procedures
Additional Experimental Procedures can be found in Supplemental Experi-
mental Procedures available with this article online.
SUPPLEMENTAL INFORMATION
The Supplemental Information include five figures, Supplemental Experi-
mental Procedures, and one table and can be found with this article online
at doi:10.1016/j.immuni.2009.11.012.
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